Search This Blog

Wednesday, October 30, 2019

iRadimed EPS beats by $0.07, beats on revenue

iRadimed (NASDAQ:IRMD): Q3 Non-GAAP EPS of $0.23; GAAP EPS of $0.20 beats by $0.07.
Revenue of $9.96M (+30.9% Y/Y) beats by $0.06M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.